Down More Than 60% From Its High, Has Oracle Stock Become a Bargain Buy?

The market is reacting to a simple truth: for ORCL, the equity story has shifted from earnings growth to capital intensity. A low forward P/E is not automatically cheap when the company is funding a larger asset base with more leverage and potential dilution; in that regime, the key variable is incremental ROIC versus WACC, not headline growth. If utilization ramps slowly, the apparent multiple discount can be a value trap because free cash flow is being pre-committed to infrastructure before demand is fully proven.

Second-order beneficiaries are the AI supply chain names that monetize spending immediately, especially NVDA, while the risk sits with any vendor whose order book is being used as a proxy for end-demand quality. If ORCL or peers later slow deployments, the market usually re-rates the whole AI infrastructure cohort, first through multiple compression and then through lower hardware/software growth expectations. Credit is the cleaner tell: widening spreads or more expensive financing would confirm that the burden is moving from the income statement to the balance sheet.

The contrarian miss is that consensus is treating this as a cheap-stock entry point instead of a financing/execution test. Over the next 1-3 months, the stock can bounce on any AI narrative refresh, but the 6-18 month outcome depends on whether management can show capacity utilization, backlog monetization, and stable leverage. Falsifiers are straightforward: capex flattening, liabilities stabilizing, or evidence that incremental AI revenue is flowing through with high margin and low churn.